PROS1 and COVID-19: The rationale behind focusing on developing the peptide vaccine platform for immunizations against COVID-19 was to overcome the limitations of utilizing only the whole S protein of the Wuhan strain that was the target antigen in the first generation of COVID-19 vaccines.